Hasil Pencarian - Xiao-Peng Tian
- Menampilkan 1 - 13 hasil dari 13
-
1
Brusatol modulates diverse cancer hallmarks and signaling pathways as a potential cancer therapeutic oleh Song-Bin Guo, Wei-Juan Huang, Xiao-Peng Tian
Diterbitkan 2022-07-01
Artikel -
2
Comprehensive scientometrics and visualization study profiles lymphoma metabolism and identifies its significant research signatures oleh Song-Bin Guo, Song-Bin Guo, Dan-Qi Pan, Ning Su, Man-Qian Huang, Man-Qian Huang, Zhen-Zhong Zhou, Zhen-Zhong Zhou, Wei-Juan Huang, Xiao-Peng Tian, Xiao-Peng Tian
Diterbitkan 2023-09-01
Artikel -
3
-
4
-
5
A scientometrics and visualization analysis of oxidative stress modulator Nrf2 in cancer profiles its characteristics and reveals its association with immune response oleh Song-Bin Guo, Sheng Du, Ke-Yu Cai, Han-Jia Cai, Wei-Juan Huang, Xiao-Peng Tian
Diterbitkan 2023-06-01
Artikel -
6
-
7
-
8
The β-catenin-LINC00183-miR-371b-5p-Smad2/LEF1 axis promotes adult T-cell lymphoblastic lymphoma progression and chemoresistance oleh Wei-Juan Huang, Song-Bin Guo, Hui Shi, Xin-Ling Li, Yong Zhu, Mei Li, Li-Yan Song, Rong-Min Yu, Qing-Qing Cai, Xiao-Peng Tian
Diterbitkan 2023-04-01
Artikel -
9
Novel target and treatment agents for natural killer/T-cell lymphoma oleh Xiao-Peng Tian, Yi Cao, Jun Cai, Yu-Chen Zhang, Qi-Hua Zou, Jin-Ni Wang, Yu Fang, Jia-Hui Wang, Song-Bin Guo, Qing-Qing Cai
Diterbitkan 2023-07-01
Artikel -
10
-
11
Mechanism of Abnormal Coagulation Induced by Tigecycline in Cancer Patients oleh Li-Hua Sun, Kun-Hao Bai, Kun-Hao Bai, Guo-Yan Wu, Xiao-Peng Tian, Zhi-Qing Zou, Da-Wei Wang, Yu-Jun Dai, Yu-Jun Dai, Si-Liang Chen
Diterbitkan 2022-07-01
Artikel -
12
BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T‐cell lymphoblastic lymphoma oleh Xiao‐Peng Tian, Jun Cai, Shu‐Yun Ma, Yu Fang, Hui‐Qiang Huang, Tong‐Yu Lin, Hui‐Lan Rao, Mei Li, Zhong‐Jun Xia, Tie‐Bang Kang, Dan Xie, Qing‐Qing Cai
Diterbitkan 2020-06-01
Artikel -
13
Efficacy and safety of decitabine combined with HAAG (homoharringtonine, aclarubicin, low-dose cytarabine and G-CSF) for newly diagnosed acute myeloid leukemia oleh Jun-Feng Zhu, Jun-Feng Zhu, Jun-Feng Zhu, Hai-Ping Dai, Hai-Ping Dai, Qian-Qian Zhang, Qian-Qian Zhang, Jia Yin, Jia Yin, Zheng Li, Zheng Li, Qin-Ya Cui, Qin-Ya Cui, Xiao-Peng Tian, Xiao-Peng Tian, Si-Ning Liu, Si-Ning Liu, Zheng-Ming Jin, Zheng-Ming Jin, Xia-Ming Zhu, Xia-Ming Zhu, De-Pei Wu, De-Pei Wu, Xiao-Wen Tang, Xiao-Wen Tang
Diterbitkan 2022-10-01
Artikel